2019 Marfan Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Marfan Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Marfan Syndrome. It presents in-depth analysis of Marfan Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Marfan Syndrome.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Marfan Syndrome clinical trials by-
The research work is prepared through extensive and continuous research on Marfan Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Marfan Syndrome clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Marfan Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Marfan Syndrome patients are identified
- The report includes panorama of Marfan Syndrome clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Marfan Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Marfan Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Marfan Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Marfan Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Marfan Syndrome Treatment, 2019
3. REGION WISE MARFAN SYNDROME CLINICAL TRIALS
3.1 Asia Pacific Marfan Syndrome Clinical Trials by Country
3.2 Europe Marfan Syndrome Clinical Trials by Country
3.3 North America Marfan Syndrome Clinical Trials by Country
3.4 Middle East and Africa Marfan Syndrome Clinical Trials by Country
3.5 South and Central America Marfan Syndrome Clinical Trials by Country
4. MARFAN SYNDROME CLINICAL TRIAL TRENDS
4.1 Start Year wise Marfan Syndrome Clinical Trials
4.2 Phase wise Marfan Syndrome Clinical Trials
4.3 Trial Status wise Marfan Syndrome Clinical Trials
4.4 Trial Type wise Marfan Syndrome Clinical Trials
5. MARFAN SYNDROME AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Marfan Syndrome Trials by Year
5.2 Average Enrollment in Marfan Syndrome Trials by Phase
5.3 Average Enrollment in Marfan Syndrome Trials by Status
5.4 Average Enrollment in Marfan Syndrome Trials by Type of Trial
6. COMPANIES PARTICIPATING IN MARFAN SYNDROME CLINICAL TRIALS
6.1 Marfan Syndrome Trials by Sponsor Type
6.2 Marfan Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Marfan Syndrome Trials- Phase
7.2 Marfan Syndrome Trials- Phase
7.3 Marfan Syndrome Trials- Phase
7.4 Marfan Syndrome Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Marfan Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Marfan Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Marfan Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Marfan Syndrome Treatment, 2019
3. REGION WISE MARFAN SYNDROME CLINICAL TRIALS
3.1 Asia Pacific Marfan Syndrome Clinical Trials by Country
3.2 Europe Marfan Syndrome Clinical Trials by Country
3.3 North America Marfan Syndrome Clinical Trials by Country
3.4 Middle East and Africa Marfan Syndrome Clinical Trials by Country
3.5 South and Central America Marfan Syndrome Clinical Trials by Country
4. MARFAN SYNDROME CLINICAL TRIAL TRENDS
4.1 Start Year wise Marfan Syndrome Clinical Trials
4.2 Phase wise Marfan Syndrome Clinical Trials
4.3 Trial Status wise Marfan Syndrome Clinical Trials
4.4 Trial Type wise Marfan Syndrome Clinical Trials
5. MARFAN SYNDROME AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Marfan Syndrome Trials by Year
5.2 Average Enrollment in Marfan Syndrome Trials by Phase
5.3 Average Enrollment in Marfan Syndrome Trials by Status
5.4 Average Enrollment in Marfan Syndrome Trials by Type of Trial
6. COMPANIES PARTICIPATING IN MARFAN SYNDROME CLINICAL TRIALS
6.1 Marfan Syndrome Trials by Sponsor Type
6.2 Marfan Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Marfan Syndrome Trials- Phase
7.2 Marfan Syndrome Trials- Phase
7.3 Marfan Syndrome Trials- Phase
7.4 Marfan Syndrome Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Marfan Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 9: Marfan Syndrome Clinical Trials by Phase
Figure 10: Marfan Syndrome Clinical Trials by Trial Status
Figure 11: Marfan Syndrome Clinical Trials by Type
Figure 12: Marfan Syndrome Clinical Trials by Sponsor Type
Figure 13: Marfan Syndrome Clinical Trials by Leading Sponsors
Figure 14: Marfan Syndrome Average Enrollment by Phase
Figure 15: Marfan Syndrome Average Enrollment by Trial Status
Figure 16: Marfan Syndrome Average Enrollment by Type
Figure 17: Marfan Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Marfan Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Marfan Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Figure 9: Marfan Syndrome Clinical Trials by Phase
Figure 10: Marfan Syndrome Clinical Trials by Trial Status
Figure 11: Marfan Syndrome Clinical Trials by Type
Figure 12: Marfan Syndrome Clinical Trials by Sponsor Type
Figure 13: Marfan Syndrome Clinical Trials by Leading Sponsors
Figure 14: Marfan Syndrome Average Enrollment by Phase
Figure 15: Marfan Syndrome Average Enrollment by Trial Status
Figure 16: Marfan Syndrome Average Enrollment by Type
Figure 17: Marfan Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Marfan Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Marfan Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Marfan Syndrome Average Enrollment by Phase
Table 15: Marfan Syndrome Average Enrollment by Trial Status
Table 16: Marfan Syndrome Average Enrollment by Type
Table 17: Marfan Syndrome- Average Enrolment by Type of Sponsors
Table 18: Marfan Syndrome- Enrolment by Leading Sponsors
Table 1: Marfan Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Marfan Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Marfan Syndrome Average Enrollment by Phase
Table 15: Marfan Syndrome Average Enrollment by Trial Status
Table 16: Marfan Syndrome Average Enrollment by Type
Table 17: Marfan Syndrome- Average Enrolment by Type of Sponsors
Table 18: Marfan Syndrome- Enrolment by Leading Sponsors
